Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer.

@article{Mller1997ExpressionAP,
  title={Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer.},
  author={Werner Alois M{\"u}ller and Anthony Gerard Schneiders and Karl Heinz Heider and Sven Meier and Gerhard Hommel and Helmut Erich Gabbert},
  journal={The Journal of pathology},
  year={1997},
  volume={183 2},
  pages={222-7}
}
In the present study, the expression and prognostic role of the CD44 splicing variants v5 and v6 were immunohistochemically investigated in 418 curatively resected gastric carcinomas. CD44v5 was expressed in 65.3 per cent (n = 273) and CD44v6 in 77.0 per cent (n = 322) of the tumours. Whereas the expression of CD44v5 was correlated with advanced pT categories, with lymph node involvement, and with the presence of blood and lymphatic vessel invasion, such a correlation could not be found for the… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

CD44v6 is not relevant in colorectal tumour progression

International Journal of Colorectal Disease • 2002
View 6 Excerpts
Highly Influenced

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer.

Cancer research and treatment : official journal of Korean Cancer Association • 2016

CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology • 2016

CD44 family proteins in gastric cancer: a meta-analysis and narrative review.

International journal of clinical and experimental medicine • 2015

Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis.

International journal of clinical and experimental medicine • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…